Clover Health CEO Wai Conrad sold 15,203 shares of Class A Common Stock on July 8, 2025, according to a regulatory filing. The transactions amounted to approximately $49,561.
The shares were sold at prices ranging from $3.25 to $3.27 per share. This insider transaction was reported on July 11, 2025.
Insider selling, even in smaller volumes, is often observed by investors as a data point regarding executive sentiment towards the company's valuation.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.